Pioglitazone increases renal tubular cell albumin uptake but limits proinflammatory and fibrotic responses

Kidney International

Volumn 65, Issue 5, 2004, Pages 1647-1653

  Zafiriou, Stephen ^b   Stanners, Scott R ^b   Polhill, Tania S ^b   Poronnik, Philip ^b   Pollock, Carol A ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b NONE

Author keywords

Albumin; Monocyte chemo attractant protein 1; Peroxisome proliferator activated receptor; Proximal tubule cell; Transforming growth factor 1

Indexed keywords

ALBUMIN; ANTIINFLAMMATORY AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PIOGLITAZONE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG EXPOSURE; KIDNEY CELL; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; NEPHRITIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN TRANSPORT; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 2342473267     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00574.x     Document Type: Conference Paper

References (30)

1. WAPSTRA FH, NAVIS G, DE JONG PE, DE ZEEUW D: Prognostic value of the short-term antiproteinuric response to ACE inhibition for prediction of GFR decline in patients with nondiabetic renal disease. Exp Nephrol 4 (Suppl 1):47-52, 1996
2. BREYER JA, BAIN RP, EVANS JK, et al: Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. The Collaborative Study Group. Kidney Int 50:1651-1658, 1996
3. PETERSON JC, ADLER S, BURKART JM, et al: Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 123:754-762, 1995
4. RUGGENENTI P, PERNA A, MOSCONI L, et al: Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN). Kidney Int 53:1209-1216, 1998
5. JAFAR TH, STARK PC, SCHMID CH, et al: Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. Kidney Int 60:1131-1140, 2001
6. ZOJA C, MORIGI M, REMUZZI G: Proteinuria and phenotypic change of proximal tubular cells. J Am Soc Nephrol 14:S36-S41, 2003
7. DONADELLI R, ABBATE M, ZANCHI C, et al: Protein traffic activates NF-kB gene signaling and promotes MCP-1-dependent interstitial inflammation. Am J Kidney Dis 36:1226-1241, 2000
8. DOMINGUEZ JH, TANG N, XU W, et al: Studies of renal injury. III. Lipid-induced nephropathy in type II diabetes. Kidney Int 57:92-104, 2000
9. FRIED LF, ORCHARD TJ, KASISKE BL: Effect of lipid reduction on the progression of renal disease: A meta-analysis. Kidney Int 59:260-269, 2001
10. GUAN Y: Targeting perorisome proliferator-activated receptors (PPARs) in kidney and urologic disease. Minerva Urol Nefrol 54:65-79, 2002
11. FUJII M, TAKEMURA R, YAMAGUCHI M, et al: Troglitazone (CS-045) ameliorates albuminuria in streptozotodn-induced diabetic rats. Metabolism 46:981-983, 1997
12. IMANO E, KANDA T, NAKATANI Y, et al: Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy. Diabetes Care 21:2135-2139, 1998
13. BUCKINGHAM RE, AL-BARAZANJI KA, TOSELAND CD, et al: Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats. Diabetes 47:1326-1334, 1998
14. JIANG C, TING AT, SEED B: PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82-86, 1998
15. RICOTE M, LI AC, WILLSON TM, et al: The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391:79-82, 1998
16. ZHENG F, FORNONI A, ELLIOT SJ, et al: Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation. Am J Physiol Renal Physiol 282:F639-F648, 2002
17. MA LJ, MARCANTONI C, LINTON MF, et al: Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats. Kidney Int 59:1899-1910, 2001
18. POYNTER ME, DAYNES RA: Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging. J Biol Chem 273:32833-32841, 1998
19. RUAN H, POWNALL HJ, LODISH HF: Troglitazone antagonizes TNF-alpha-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-kB. J Biol Chem 278:28181-28192, 2003
20. GUAN Y, ZHANG Y, DAVIS L, BREYER MD: Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans. Am J Physiol 273:F1013-F1022, 1997
21. GUAN Y, BREYER MD: Peroxisome proliferator-activated receptors (PPARs): Novel therapeutic targets in renal disease. Kidney Int 60:14-30, 2001
22. BAOUTINA A, DEAN RT, JESSUP W: Alpha-tocopherol supplementation of macrophages does not influence their ability to oxidize LDL. J Lipid Res 39:114-130, 1998
23. WANG Y, CHEN J, CHEN L, et al: Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J Am Soc Nephrol 8:1537-1545, 1997
24. ZOJA C, DONADELLI R, COLLEONI S, et al: Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. Kidney Int 53:1608-1615, 1998
25. TANG S, LEUNG JC, ABE K, et al: Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. J Clin Invest 111:515-527, 2003
26. LEE EM, POLLOCK CA, DRUMM K, et al: Effects of pathophysiological concentrations of albumin on NHE3 activity and cell proliferation in primary cultures of human proximal tubule cells. Am J Physiol Renal Physiol 285:F748-F757, 2003
27. NIEMEYER NV, JANNEY LM: Thiazolidinedione-induced edema. Pharmacotherapy 22:924-929, 2002
28. RUAN XZ, MOORHEAD JF, FERNANDO R, et al: PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway. J Am Soc Nephrol 14:593-600, 2003
29. CHINETTI G, GRIGLIO S, ANTONUCCI M, et al: Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J Biol Chem 273:25573-25580, 1998
30. PING D, JONES PL, BOSS JM: TNF regulates the in vivo occupancy of both distal and proximal regulatory regions of the MCP-1/JE gene. Immunity 4:455-469, 1996